Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
ResMed
RMD
$30.6B
| $359K | ﹤0.01% |
1,643
-2,219
| -57% | -$495K |
|
1627
Ultrapar
UGP
$6.95B
| $358K | ﹤0.01% |
91,182
-31,240
| -26% | -$103K |
|
1628
Regency Centers
REG
$14.7B
| $358K | ﹤0.01% |
+5,799
| New | +$345K |
|
|
OSG
1629
Octave Specialty Group
OSG
$243M
| $354K | ﹤0.01% |
24,839
| – | – |
|
1630
Western Digital
WDC
$188B
| $351K | ﹤0.01% |
12,246
+3,516
| +40% | +$97.8K |
|
1631
Zimmer Biomet
ZBH
$18.2B
| $340K | ﹤0.01% |
+2,333
| New | +$317K |
|
1632
Expedia Group
EXPE
$35.4B
| $332K | ﹤0.01% |
3,034
-16,856
| -85% | -$1.65M |
|
|
PARA
1633
DELISTED
Paramount Global Class B
PARA
| $332K | ﹤0.01% |
20,848
-89,648
| -81% | -$1.62M |
|
1634
Royal Caribbean
RCL
$85.1B
| $331K | ﹤0.01% |
3,190
-5,122
| -62% | -$402K |
|
1635
GE HealthCare
GEHC
$30.7B
| $330K | ﹤0.01% |
+4,068
| New | +$325K |
|
1636
Citizens Financial Services
CZFS
$373M
| $327K | ﹤0.01% |
4,481
-1,279
| -22% | -$104K |
|
1637
Lexicon Pharmaceuticals
LXRX
$1.03B
| $325K | ﹤0.01% |
142,006
-9,487
| -6% | -$25.2K |
|
1638
Bio-Rad Laboratories Class A
BIO
$8.71B
| $325K | ﹤0.01% |
856
-1,444
| -63% | -$588K |
|
1639
Marathon Digital Holdings
MARA
$4.32B
| $317K | ﹤0.01% |
22,898
-11,296
| -33% | -$114K |
|
1640
Boston Properties
BXP
$11.2B
| $316K | ﹤0.01% |
+5,483
| New | +$285K |
|
1641
Bit Digital
BTBT
$463M
| $313K | ﹤0.01% |
+77,154
| New | +$200K |
|
|
GBIO
1642
DELISTED
Generation Bio
GBIO
| $308K | ﹤0.01% |
+5,597
| New | +$257K |
|
1643
Tower Semiconductor
TSEM
$24.8B
| $307K | ﹤0.01% |
8,341
-53,253
| -86% | -$2.2M |
|
1644
iShares Russell Mid-Cap ETF
IWR
$56.3B
| $307K | ﹤0.01% |
4,200
| – | – |
|
1645
Qorvo
QRVO
$7.99B
| $305K | ﹤0.01% |
2,991
-3,241
| -52% | -$311K |
|
1646
New Oriental
EDU
$9.37B
| $303K | ﹤0.01% |
7,664
-321,011
| -98% | -$12.8M |
|
1647
iShares MSCI Saudi Arabia ETF
KSA
$622M
| $301K | ﹤0.01% |
7,290
| – | – |
|
|
GRVY
1648
GRAVITY
GRVY
$430M
| $301K | ﹤0.01% |
4,284
| – | – |
|
1649
Sabesp
SBS
$19.1B
| $299K | ﹤0.01% |
130,419
-2,068
| -2% | -$4.14K |
|
1650
Lear
LEA
$6.54B
| $299K | ﹤0.01% |
2,082
+313
| +18% | +$41.3K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.